Inve US ▾
BLBLCO

Bausch + Lomb (BLCO) Q2 FY26 earnings call

Earnings call· Jun 2026 (Q2 FY26)· Health Care· Jul 29, 2026

Source: earnings call transcript

Bausch + Lomb delivered another strong quarter, showcasing broad-based revenue growth and significant margin expansion, which is translating into robust cash flow generation and deleveraging. The company reiterated its commitment to its three-year plan, driven by consistent execution, strategic product mix shifts, and continued investment in a diversified pipeline, leading to a raised full-year outlook.

You’re reading a preview. Opening the full call uses 1 concall credit.

Sign in to use your monthly call allowance.

Inve summary of the company's earnings call; see how call summaries are prepared. Not investment advice.